Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. [electronic resource] by
- Mody, Rajen
- Naranjo, Arlene
- Van Ryn, Collin
- Yu, Alice L
- London, Wendy B
- Shulkin, Barry L
- Parisi, Marguerite T
- Servaes, Sabah-E-Noor
- Diccianni, Mitchell B
- Sondel, Paul M
- Bender, Julia G
- Maris, John M
- Park, Julie R
- Bagatell, Rochelle
Producer: 20170911
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
16.
|
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group. [electronic resource] by
- Mody, Rajen
- Yu, Alice L
- Naranjo, Arlene
- Zhang, Fan F
- London, Wendy B
- Shulkin, Barry L
- Parisi, Marguerite T
- Servaes, Sabah-E-Noor
- Diccianni, Mitchell B
- Hank, Jacquelyn A
- Felder, Mildred
- Birstler, Jennifer
- Sondel, Paul M
- Asgharzadeh, Shahab
- Glade-Bender, Julia
- Katzenstein, Howard
- Maris, John M
- Park, Julie R
- Bagatell, Rochelle
Producer: 20210202
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|